Coronavirus (COVID-19) Resource Center

Professionals

Name	Title	Office	Email
Chris Bator Cleveland +1.216.861.7372 Counsel Chris Bator	Counsel	Cleveland	cbator@bakerlaw.com
Edward J. Bernert Columbus +1.614.462.2687 Partner Edward J. Bernert	Partner	Columbus	ebernert@bakerlaw.com
Daniel J. Buzzetta New York +1.212.589.4236 Partner Daniel J. Buzzetta	Partner	New York	dbuzzetta@bakerlaw.com
Phillip M. Callesen Cleveland +1.216.861.7884 Partner Phillip M. Callesen	Partner	Cleveland	pcallesen@bakerlaw.com
Christopher J. Carolan New York +1.212.589.4658 Partner Christopher J. Carolan	Partner	New York	ccarolan@bakerlaw.com
Joseph L. Chairez Costa Mesa +1.714.966.8822 Partner Joseph L. Chairez	Partner	Costa Mesa	jchairez@bakerlaw.com
Mark A. Cymrot Washington, D.C. +1.202.861.1677 Partner Mark A. Cymrot	Partner	Washington, D.C.	mcymrot@bakerlaw.com
Sashe D. Dimitroff Houston +1.713.646.1320 Partner Sashe D. Dimitroff	Partner	Houston	sdimitroff@bakerlaw.com
Michael A. Ferguson Washington, D.C. +1.202.861.1663 Senior Advisor Michael A. Ferguson	Senior Advisor	Washington, D.C.	mferguson@bakerlaw.com
David M. Friebus Chicago +1.312.416.6234 Partner David M. Friebus	Partner	Chicago	dfriebus@bakerlaw.com
Lisa M. Ghannoum Cleveland +1.216.861.7872 Partner Lisa M. Ghannoum	Partner	Cleveland	lghannoum@bakerlaw.com
John M. Gherlein Cleveland +1.216.861.7398 Partner John M. Gherlein	Partner	Cleveland	jgherlein@bakerlaw.com
May Tal Gongolevsky New York +1.212.589.4213 Partner May Tal Gongolevsky	Partner	New York	mgongolevsky@bakerlaw.com
Elizabeth A. Green Orlando +1.407.649.4036 Partner Elizabeth A. Green	Partner	Orlando	egreen@bakerlaw.com
Kurt P. Gruber Orlando +1.407.649.4042 Partner Kurt P. Gruber	Partner	Orlando	kgruber@bakerlaw.com
Seth J. Hanft Columbus +1.614.462.4778 Counsel Seth J. Hanft	Counsel	Columbus	shanft@bakerlaw.com
Michelle M. Hervey Cleveland +1.216.861.7290 Partner Michelle M. Hervey	Partner	Cleveland	mhervey@bakerlaw.com
Susan Whittaker Hughes Cleveland +1.216.861.7841 Partner Susan Whittaker Hughes	Partner	Cleveland	shughes@bakerlaw.com
Nancy Inesta Los Angeles +1.310.442.8833 Partner Nancy Inesta	Partner	Los Angeles	ninesta@bakerlaw.com
Edward J. Jacobs New York +1.212.589.4674 Partner Edward J. Jacobs	Partner	New York	ejacobs@bakerlaw.com
Christian B. Jones Washington, D.C. +1.202.861.1617 Senior Advisor Christian B. Jones	Senior Advisor	Washington, D.C.	cjones@bakerlaw.com
Mark A. Kadzielski Los Angeles +1.310.442.8815 Partner Mark A. Kadzielski	Partner	Los Angeles	mkadzielski@bakerlaw.com
Gilbert S. Keteltas Washington, D.C. +1.202.861.1530 Partner Gilbert S. Keteltas	Partner	Washington, D.C.	gketeltas@bakerlaw.com
Jay P. Krupin Washington, D.C. +1.202.861.1700 Partner Jay P. Krupin	Partner	Washington, D.C.	jkrupin@bakerlaw.com
L. Poe Leggette Houston / Denver +1.713.276.1647 / +1.303.764.4020 Partner L. Poe Leggette	Partner	Houston	pleggette@bakerlaw.com
John R. Lehrer II Washington, D.C. +1.202.861.1620 Partner John R. Lehrer II	Partner	Washington, D.C.	jlehrer@bakerlaw.com
Charlene L. McGinty Atlanta +1.404.256.8232 Partner Charlene L. McGinty	Partner	Atlanta	cmcginty@bakerlaw.com
John Melicharek Jr. Orlando / New York +1.407.649.4086 / +1.212.589.4284 Partner John Melicharek Jr.	Partner	Orlando	jmelicharek@bakerlaw.com
Jennifer A. Mills Cleveland +1.216.861.7874 Partner Jennifer A. Mills	Partner	Cleveland	jmills@bakerlaw.com
William Oxley Los Angeles +1.310.442.8894 Partner William Oxley	Partner	Los Angeles	woxley@bakerlaw.com
Jeffrey H. Paravano Washington, D.C. +1.202.861.1770 Partner Jeffrey H. Paravano	Partner	Washington, D.C.	jparavano@bakerlaw.com
Laurin D. Quiat Denver +1.303.764.4136 Partner Laurin D. Quiat	Partner	Denver	lquiat@bakerlaw.com
Kenneth B. Reisenfeld Washington, D.C. +1.202.861.1545 Partner Kenneth B. Reisenfeld	Partner	Washington, D.C.	kreisenfeld@bakerlaw.com
Jorian L. Rose New York +1.212.589.4681 Partner Jorian L. Rose	Partner	New York	jrose@bakerlaw.com
Lee H. Rosebush Washington, D.C. +1.202.861.1567 Partner Lee H. Rosebush	Partner	Washington, D.C.	lrosebush@bakerlaw.com
Nathan A. Schacht Denver +1.303.764.4029 Counsel Nathan A. Schacht	Counsel	Denver	nschacht@bakerlaw.com
Michael J. Semes Philadelphia +1.215.564.8270 Of Counsel Michael J. Semes	Of Counsel	Philadelphia	msemes@bakerlaw.com
Lynn Sessions Houston +1.713.646.1352 Partner Lynn Sessions	Partner	Houston	lsessions@bakerlaw.com
Lance L. Shea M.S., J.D. Washington, D.C. +1.202.861.1648 Partner Lance L. Shea M.S., J.D.	Partner	Washington, D.C.	lshea@bakerlaw.com
James A. Sherer New York +1.212.589.4279 Partner James A. Sherer	Partner	New York	jsherer@bakerlaw.com
Janet A. Spreen Cleveland +1.216.861.7564 Partner Janet A. Spreen	Partner	Cleveland	jspreen@bakerlaw.com
Trevor M. Stanley Washington, D.C. +1.202.861.1551 Partner Trevor M. Stanley	Partner	Washington, D.C.	tstanley@bakerlaw.com
Todd J. Thorson Dallas +1.214.210.1222 Partner Todd J. Thorson	Partner	Dallas	tthorson@bakerlaw.com
Amy J. Traub New York +1.212.589.4248 Partner Amy J. Traub	Partner	New York	atraub@bakerlaw.com
W. Ray Whitman Houston / Dallas +1.713.646.1367 / +1.214.210.1200 Partner W. Ray Whitman	Partner	Houston	rwhitman@bakerlaw.com

News

News

• 4/2/2020
  Jay Krupin, COVID-19 Employment Task Force Lauded by Hospitality Publication
• 4/1/2020
  Seth Hanft Talks to "Tax Notes" about CARES Act Options for Retirement Plan Participants
• 3/31/2020
  Alan Friel Supports Calls for Delay in Enforcement of CCPA
• 3/22/2020
  Ed Beckwith Talks to NBC News about Advance Directives in Wake of Coronavirus Fears
• 3/18/2020
  Amy Traub Talks about How Lawyers are Supporting Business during Coronavirus Crisis
• 3/13/2020
  Nancy Inesta Talks to "Wall Street Journal" about How Much Employers Can Ask Workers about Their Health
• 3/13/2020
  Lynn Sessions Talks about Security of Work-from-Home Arrangements
• 3/12/2020
  Lynn Sessions Discusses Privacy Issues Faced by Employers in Battling Coronavirus
• 3/6/2020
  Nathan Schacht Talks to Law360 about Coronavirus Scenarios Facing Employers
• 3/3/2020
  Nancy Inesta Talks about What Employers Can Do about Coronavirus Threat

Publications

Alerts

• 4/9/2020
  The Employee Retention Tax Credit: Aggregation Aggravation
• 4/8/2020
  FDA and State Boards of Pharmacy React to COVID-19 – April 8 Update
• 4/8/2020
  SEC's Office of the Chief Accountant Issues a Statement on Financial Reporting in COVID-19 Environment
• 4/8/2020
  Los Angeles's COVID-19 Sick Leave Ordinance
• 4/7/2020
  FAQs: The Families First Coronavirus Response Act for Employers
• 4/7/2020
  COVID-19 Legislation – Healthcare Industry Impacts Deeper Dive into the CARES Act
• 4/7/2020
  Empire State Development's Guidance to New York Governor's Executive Order No. 202.6 as it Relates to the Real Estate Industry: What Real Estate Services are Considered Essential Businesses?
• 4/7/2020
  COVID-19 Crisis Raises Enforcement and Litigation Risks for Disclosures by Public Issuers
• 4/7/2020
  On the Heels of the CARES Act, Companies Should Prepare for Increased Prosecutions and Enforcement Activity
• 4/6/2020
  FAQs: The Coronavirus Aid, Relief and Economic Security (CARES) Act: What It Means for Employers
• 4/6/2020
  COVID-19 and the Emergency Exception to the Duty to Bargain
• 4/6/2020
  Georgia Gov. Brian Kemp Issues Statewide Stay-at-Home Order Affecting Individuals and Businesses
• 4/6/2020
  COVID19 Update: Anti-Hoarding Enforcement
• 4/6/2020
  FAQs: COVID-19 – General Labor and Employment Legal Concerns – April 6, 2020 Update
• 4/6/2020
  COVID-19 Eviction Moratoria: New Rules Affecting Landlords and Tenants
• 4/3/2020
  Ohio's Governor Issues Executive Order Requesting Forbearance by Lenders, Landlords
• 4/3/2020
  Due to the COVID-19 Pandemic, HHS Eases Restrictions on the Use and Disclosure of PHI by Business Associates
• 4/3/2020
  Coronavirus Relief Legislation Includes Incentives for Charitable Giving
• 4/2/2020
  Commercial Real Estate Closings in the COVID-19 Climate: Practical Considerations
• 4/2/2020
  CMS Continues to Create Additional Regulatory Flexibilities in Efforts to Reduce Provider Burden and Focus on Patient Care
• 4/2/2020
  FAQs: COVID-19 – Employee Benefits Updates
• 4/2/2020
  Understanding the Landlord, Condominium Association and Property Manager Duties During the COVID-19 Crisis
• 4/2/2020
  Small-to-Mid-Cap Businesses Impacted by COVID-19 Could See Change in SEC Filer Status
• 4/2/2020
  Does a Governmental Order Requiring that Businesses Close to Prevent the Further Spread of COVID-19 Amount to a Regulatory Taking of Property that Entitles a Commercial Tenant to Relief?
• 4/1/2020
  FAQs for Small-Business Healthcare Providers about the Paycheck Protection Program
• 4/1/2020
  FAQs: The Potential Risk of Audits and Enforcement of Misconduct Related to the Loans and Other Financial Benefits Programs Available Under the CARES Act
• 4/1/2020
  FDA and State Boards of Pharmacy React to COVID-19 – April 1 Update
• 4/1/2020
  CMS Issues Stark Law Waivers for COVID-19 Purposes
• 4/1/2020
  Philadelphia Extends Filing, Tax Payment and Estimated Payment Due Dates and Loosens City Wage Tax Withholding Policy
• 4/1/2020
  CARES Act Significantly Revises Part 2 Rules to Better Align with HIPAA
• 4/1/2020
  CARES Act Authorizes Funding for Midsize Lending Program
• 3/31/2020
  FAQs: CMS Expands Accelerated and Advance Payments Program in Response to COVID-19
• 3/31/2020
  Energy Contracts: In-House Counsel, Force Majeure, and the COVID-19 Pandemic
• 3/30/2020
  Recently Issued Insurance Guidance Will Impact Ohio Employment-Based Health Plans
• 3/30/2020
  FAQs: COVID-19 – General Labor and Employment Legal Concerns – March 30, 2020 Update
• 3/30/2020
  SEC Provides Guidance Regarding COVID-19 Disclosures
• 3/30/2020
  Temporary U.S. EPA Enforcement Discretion in Response to COVID-19
• 3/27/2020
  Ohio Extending Income Tax Filing and Payment Deadline
• 3/27/2020
  SEC Offers Expanded Filing Extensions to Public Companies Grappling With the Effects of COVID-19
• 3/27/2020
  FDA and State Boards of Pharmacy React to Coronavirus – March 27 Update
• 3/27/2020
  Implications Of The Coronavirus Aid, Relief, and Economic Security (CARES) Act – Healthcare Providers
• 3/27/2020
  SEC Watching for Bad Actors and Preserving Market Integrity During Challenging Times Caused By COVID-19
• 3/27/2020
  President Signs $2 Trillion CARES Act With Significant Tax and Workforce Relief for Businesses and Individuals
• 3/27/2020
  Ohio COVID-19 Tax Relief Legislation
• 3/26/2020
  CARES Act to Provide Significant Employee Benefit Plan Relief for Participants and Plan Sponsors
• 3/26/2020
  Federal Government Assumes Small Business Losses Through Forgivable Paycheck Protection Program Loans
• 3/26/2020
  NMTC Considerations in Respect of COVID-19 Crisis
• 3/26/2020
  Take Note of Cuomo's Suspension of Statute of Limitations
• 3/26/2020
  COVID-19 – Commercial Leases: What Landlords and Tenants Should Know
• 3/26/2020
  Superintendent's Response to New York Governor's Executive Order 202.9 – New Part 119 to 3NYCRR
• 3/26/2020
  Individual Income Tax Implications of the Coronavirus Aid, Relief, and Economic Security (CARES) Act
• 3/25/2020
  FAQs: COVID-19 – Federal and State Tax Updates
• 3/25/2020
  A Primer on the Effects and Implications of New York Governor's Executive Order No. 202.9: Necessary Relief for Businesses and Consumers – Challenges and Uncertainty for Licensed or Regulated Entities
• 3/25/2020
  COVID-19 and U.S. Statutes of Limitation
• 3/25/2020
  Immunity From Liability for Persons Engaged in Medical Countermeasures Against the COVID-19 Pandemic
• 3/25/2020
  Debt Finance COVID-19: (1) Update on Fully Drawing Down Revolving Lines of Credit and (2) Considering Federal Payroll Loans and Other Relief? Now is the Time to Talk to Your Lender
• 3/25/2020
  Denver and Colorado: Staying at Home in the Mile High City
• 3/25/2020
  Summary of SBA's COVID-19 Disaster Loan Program
• 3/25/2020
  State of Georgia's Multipronged Response to COVID-19 Continues to Evolve
• 3/24/2020
  FAQs: COVID-19 - State Net Operating Loss (NOL)
• 3/24/2020
  CISA, Essential Critical Infrastructure Workers and Federal Contractors
• 3/24/2020
  Top Considerations for Essential Ohio Businesses to Sustain Operations Amid COVID-19
• 3/24/2020
  CMS Announces COVID-19 Exceptions and Extensions for Medicare Quality Reporting Programs
• 3/24/2020
  FDA Emergency Use Authorizations (EUAs): Cutting Regulatory Red Tape for COVID-19
• 3/23/2020
  HTCs Not Immune to COVID-19
• 3/23/2020
  Georgia Department of Labor Sets New Requirements for Mandatory Filing by Employers for Partial UI Claims
• 3/23/2020
  Security Considerations for Working Remotely
• 3/23/2020
  USTR Considers Removal of Tariffs on Certain Chinese Imports Needed for COVID-19 Response
• 3/23/2020
  FAQs: Families First Coronavirus Response Act Provides Tax Credits in Limited Circumstances for Paid Sick and Family Leave
• 3/23/2020
  FAQs: COVID-19 – Considerations in M&A Transactions
• 3/23/2020
  Ohio Department of Health: Business Must Cease Unless Essential. Good News, Your Business May Very Well Be Essential
• 3/23/2020
  COVID-19 – Commercial Contracts: Risk Allocation in Times of Uncertainty
• 3/23/2020
  The COVID-19 Pandemic Raises the Importance of Understanding Whether and When Documents May be Signed Electronically and Witnessed or Notarized Remotely
• 3/23/2020
  FDA and State Boards of Pharmacy React to Coronavirus – March 23 Update
• 3/23/2020
  Incentive Compensation Considerations During the COVID-19 Pandemic
• 3/22/2020
  Testing Healthcare Workers for COVID-19: Issues and Challenges
• 3/21/2020
  With States Beginning to Issue ‘Stay at Home' Orders, Focus Turns to ‘Essential' Businesses That Can Remain Open
• 3/21/2020
  CMS Approves Second Request for 1135 Medicaid Waiver
• 3/21/2020
  SEC and NFA Provide Relief and Guidance to Investment Advisers Impacted by COVID-19
• 3/20/2020
  New York Governor Temporarily Adjusts Notary Law to Permit Use of 'Audio-Video Technology'
• 3/20/2020
  Virtual Stockholder Meetings in Light of Coronavirus
• 3/20/2020
  FAQs: COVID-19 - Hospitals and Medical Staffs
• 3/20/2020
  Key COVID-19 Considerations for U.S. Discovery and Information Governance
• 3/19/2020
  FDA and State Boards of Pharmacy React to Coronavirus – March 19 Update
• 3/19/2020
  California Governor Issues Important Executive Order Relaxing CA WARN Requirements During COVID-19 State of Emergency
• 3/19/2020
  CMS Issues Guidance to Protect Nursing Home Residents From COVID-19
• 3/19/2020
  President Trump Signs the Families First Coronavirus Response Act into Law
• 3/19/2020
  COVID-19: Board Oversight and Crisis Management
• 3/19/2020
  COVID19 Update: AG Barr Issues Memo Focusing Enforcement on Corona Related Fraud and Crime
• 3/19/2020
  Your Business Health Checkup: How Asset Managers Are Thriving Through COVID-19
• 3/19/2020
  COVID-19: Public and Private Disclosures and Other Securities Issues
• 3/19/2020
  FAQs: COVID-19 – Potential Impacts to Borrowers and Lenders
• 3/19/2020
  Impact of the President's Invocation of the Defense Production Act on Federal Contractors
• 3/19/2020
  Navigating Antitrust Issues in the Wake of COVID-19
• 3/18/2020
  HHS Issues Two Important Bulletins Waiving HIPAA Sanctions During the COVID-19 National Emergency
• 3/18/2020
  Telehealth Toolkit: CMS Gives Providers Nationwide Flexibility to ‘See' Patients
• 3/18/2020
  FAQs: COVID-19 - Labor and Employment Legal Concerns
• 3/18/2020
  FAQs: COVID-19 - Force Majeure and Other Defenses to Contractual Performance
• 3/18/2020
  Coronavirus (COVID-19) Government Contracts Advisory
• 3/17/2020
  FDA and State Boards of Pharmacy React to Coronavirus – Update
• 3/17/2020
  CMS Approves First Emergency Medicaid Waiver Request to Accelerate Access to Services in Response to COVID-19
• 3/17/2020
  Have you Thought About ... How the COVID-19 Pandemic Impacts Your State and Local Tax Posture Now that Employees are Conducting More Activities from Remote Locations?
• 3/16/2020
  FDA and State Boards of Pharmacy React to Coronavirus
• 3/16/2020
  What Employers Should Know About the Families First Coronavirus Response Act
• 3/2/2020
  BakerHostetler Develops COVID-19 Employment Issues Task Force (CEIT) to Address Workplace Concerns
• 2/28/2020
  COVID–19 and the Law: Fighting the Fear with the Facts

Articles

• 3/30/2020
  Gilbert Brosky Authors Article Outlining Deterrents to Pandemic-Related Work Class Action Claims

Blog Posts

• 4/7/2020
  Combating COVID-19 Through Competitor Collaboration
• 4/3/2020
  Due to the COVID-19 Pandemic, HHS Eases Restrictions on the Use and Disclosure of PHI by Business Associates
• 4/2/2020
  COVID-19 Antitrust Agency Procedural Changes
• 4/2/2020
  3D Printing Comes of Age in the COVID-19 Crisis
• 4/1/2020
  Healthcare Providers Remain Targets for Ransomware Attacks in the Midst of COVID-19 Pandemic
• 4/1/2020
  US Patent and Trademark Office Uses Authority Granted Under CARES Act to Temporarily Extend Due Date for Certain Patent and Trademark Matters
• 3/30/2020
  COVID-19 Update: FTC and States Combat Scams, Price Gouging and Deceptive Ads
• 3/27/2020
  Patent Portfolio Considerations During Times of Financial Uncertainty
• 3/27/2020
  The Coronavirus Aid, Relief, and Economic Security Act Grants the US Patent and Trademark Office the Authority to Manage Statutory Due Dates
• 3/26/2020
  Really? Someone thinks I HEART COVID-19 should be awarded a US trademark registration?
• 3/25/2020
  Executive Order Addresses DOJ's Fight Against Hoarding Activity
• 3/23/2020
  Dealing With COVID-19 in Your Workplace Without Inviting Future Class Actions
• 3/23/2020
  Protection of Consumers and the Public in Response to the COVID-19 Pandemic
• 3/19/2020
  CORONAVIRUS UPDATE: $1 Trillion Stimulus Next Up
• 3/19/2020
  New York State Passes Statewide Paid Sick Leave Related to COVID-19
• 3/19/2020
  COVID-19 Update: Congress' Risk to Public Companies
• 3/18/2020
  COVID-19 Cybersecurity Exposure
• 3/18/2020
  Additional 6-Month CCPA Extension Sought in Wake of COVID-19
• 3/17/2020
  USPTO Waives Petition to Revive Fees for Patents, Patent Applications, Trademarks and Trademark Applications Abandoned Because of an Inability to Respond Due to COVID-19
• 3/16/2020
  FERPA Disclosures in Response to COVID-19
• 3/11/2020
  COVID-19 Update: Consumer Class Action Filed Over Hand Sanitizer Claims
• 3/9/2020
  Regulators Issue Warning: These Products Cannot Treat Coronavirus

Events

• 4/16/2020
  Webinar Series: Washington's Response to COVID-19: Senator Chris Van Hollen, D-Md.
• 4/14/2020
  Webinar Series: Washington's Response to COVID-19: Senator Thom Tillis, R-N.C.
• 4/14/2020
  Webinar: Corporate Disclosure and Enforcement Impact of COVID-19 on SEC Filings
• 4/13/2020
  Webinar: COVID-19 Pandemic: Antitrust Risks and Possible Protection Under the Defense Production Act and State Action Immunity Doctrine
• 4/9/2020
  Webinar Series: Washington's Response to COVID-19: Congressman Josh Gottheimer, D-N.J.
• 4/6/2020
  Webinar Series: Washington's Response to COVID-19: Congresswoman Stephanie Murphy, D-Fla.
• 4/2/2020
  Webinar Series: Washington's Response to COVID-19: Senator Roy Blunt, R-Mo.
• 3/31/2020
  Webinar: $2 Trillion CARES Act Provides Significant Tax and Workforce Relief for Businesses, Individuals
• 3/26/2020
  Managing COVID-19 Webinar Series: Part 3 - A Primer for Health Care Providers, Life Sciences Companies, and Insurers
• 3/25/2020
  Managing COVID-19 Webinar Series: Part 2 - Navigating Challenges in Corporate Governance & Transactions
• 3/24/2020
  Managing COVID-19 Webinar Series: Part 1 - Managing Business Continuity Impacts to the Workforce and Workplace
• 3/24/2020
  Managing COVID-19 Webinar Series: Critical Legal Issues For U.S. Businesses & Their Counsel